ÂÜÀòÂÒÂ×

Vincent Badalamenti is currently serving as the Global Pharmacovigilance Medical Director at SpringWorks Therapeutics since January 2024. Prior experience includes Associate Vice President of Pharmacovigilance at Reata Pharmaceuticals, Inc. from May 2019 to December 2023, and various leadership roles at UCB from October 2011 to May 2019, including Director & Global Safety Lead in the Patient Safety Unit for Neurology. Vincent also held the position of Director of Pharmacovigilance at King Pharmaceuticals between April 2007 and October 2011, and served as Deputy Director of Drug Safety Assurance at Bayer Pharmaceuticals from April 2001 to April 2007. The career commenced as a Post Doctoral Industrial Pharmacy Fellow at Rutgers University from July 1999 to April 2001. Vincent Badalamenti earned a Pharm.D. degree from Rutgers University, completing studies in 1999.